You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 36 No. 5, May 1979 TABLE OF CONTENTS
  Archives
  •  Online Features
  ORIGINAL ARTICLES
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (252)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Estrogen Therapy for Severe Persistent Depressions in Women

Edward L. Klaiber, MD; Donald M. Broverman, PhD; William Vogel, PhD; Yutaka Kobayashi, PhD

Arch Gen Psychiatry. 1979;36(5):550-554.


Abstract

• Positive results are reported from a double-blind study of estrogen therapy administered to severely depressed, inpatient women who had failed to respond to various conventional treatments of depression. Large doses of oral conjugated estrogen were administered for a three-month period to 23 premenopausal and postmenopausal inpatient women. Placebos were administered for a comparable period to 17 similar patients. The posttreatment Hamilton ratings of depression were significantly reduced in the estrogen-treated group, but not in the placebo group. Possible physiological mechanisms are discussed. The risk-benefit ratio for estrogen therapy of depression in these patients was judged to be favorable. However, periodic endometrial biopsies are required to monitor the endometrial response of women receiving high doses of estrogens.



Author Affiliations

From the Worcester Foundation for Experimental Biology, Shrewsbury, Mass, and the Worcester State Hospital, Worcester, Mass. Dr Kobayashi is now with the New England Nuclear Corporation, Boston.


Footnotes

Accepted for publication Oct 25, 1978.

Reprint requests to Worcester Foundation for Experimental Biology, 222 Maple Ave, Shrewsbury, MA 01545 (Dr Klaiber).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Adult female wildtype, but not oestrogen receptor {beta} knockout, mice have decreased depression-like behaviour during pro-oestrus and following administration of oestradiol or diarylpropionitrile
Walf et al.
J Psychopharmacol 2009;23:442-450.
ABSTRACT  

Oestrogen, brain function, and neuropsychiatric disorders
Cutter et al.
J. Neurol. Neurosurg. Psychiatry 2003;74:837-840.
FULL TEXT  

Estrogen Enhances Depolarization-Induced Glutamate Release through Activation of Phosphatidylinositol 3-Kinase and Mitogen-Activated Protein Kinase in Cultured Hippocampal Neurons
Yokomaku et al.
Mol. Endocrinol. 2003;17:831-844.
ABSTRACT | FULL TEXT  

Estrogen and Cognitive Functioning in Women
Sherwin
Endocr. Rev. 2003;24:133-151.
ABSTRACT | FULL TEXT  

Randomised controlled trials investigating pharmacological and psychological interventions for treatment-refractory depression: Systematic review
STIMPSON et al.
Br. J. Psychiatry 2002;181:284-294.
ABSTRACT | FULL TEXT  

Cognitive Decline Among Female Estrogen Users in Nursing Homes
Ott et al.
Journals of Gerontology Series A: Biological Sciences and Medical Sciences 2002;57:M594-598.
ABSTRACT | FULL TEXT  

Alteration in the Hypothalamic-Pituitary-Ovarian Axis in Depressed Women
Young et al.
Arch Gen Psychiatry 2000;57:1157-1162.
ABSTRACT | FULL TEXT  

Current and the near future medications for Alzheimer's disease: What can we expect from them?
Shua-Haim and Ross
AM J ALZHEIMERS DIS OTHER DEMEN 1999;14:294-307.
 

Gonadal Steroids in the Treatment of Mood Disorders
Epperson et al.
Psychosom. Med. 1999;61:676-697.
ABSTRACT | FULL TEXT  

Psychoneuroendocrine Aspects of Temporolimbic Epilepsy: Part I. Brain, Reproductive Steroids, and Emotions
Herzog
Psychosomatics 1999;40:95-101.
ABSTRACT | FULL TEXT  

Estrogen Therapy in Postmenopausal Women: Effects on Cognitive Function and Dementia
Yaffe et al.
JAMA 1998;279:688-695.
ABSTRACT | FULL TEXT  

The Psychoendocrinology of Menopause in Cross-Cultural Perspective
Charney
Transcultural Psychiatry 1996;33:413-434.
ABSTRACT  

Estrogen Replacement Therapy and Cognitive Function in Older Women
Barrett-Connor and Kritz-Silverstein
JAMA 1993;269:2637-2641.
ABSTRACT  

Actions of estrogens and progestins on nerve cells
Pfaff and McEwen
Science 1983;219:808-814.
ABSTRACT  

Imipramine: effect of ovarian steroids on modifications in serotonin receptor binding
Kendall et al.
Science 1981;211:1183-1185.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1979 American Medical Association. All Rights Reserved.